Med-X innovates, researches, and develops a variety of all-natural and alternative solutions to harmful pharmaceutical products.
Med-X has raised $1.7M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in April 2025.
Med-X's investors include StartEngine, Newchip Accelerator, Meyer Global, Hohertz Technologies, LLC.
Med-X is headquartered in Canoga Park, United States.
Med-X innovates, researches, and develops a variety of all-natural and alternative solutions to harmful pharmaceutical products.
Med-X is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Med-X — Funding & Investors." VCBacked, April 15, 2025, https://www.vcbacked.co/company/med-x. Accessed August 14, 2026.
VCBacked. (2025). Med-X — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/med-x
{{cite web |title=Med-X — Funding & Investors |url=https://www.vcbacked.co/company/med-x |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated